Improvement in precision of counting actinic keratoses

British Journal of Dermatology

Volumn 170, Issue 1, 2014, Pages 188-191

  Lee, K C ^a,b   Lew, R ^c   Weinstock, M A ^a,b,d  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; ADULT; ARTICLE; CLINICAL STUDY; CONSENSUS; CORRELATION COEFFICIENT; DERMATOLOGIST; HEALTH CARE; HUMAN; HUMAN EXPERIMENT; INSTITUTIONAL REVIEW; MEASUREMENT ACCURACY; MIDDLE AGED; POPULATION; PRIORITY JOURNAL; RELIABILITY; CONSENSUS DEVELOPMENT; DERMATOLOGY; PATHOLOGY; SKIN TUMOR; STANDARDS;

CONSENSUS; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DERMATOLOGY; HUMANS; KERATOSIS, ACTINIC; MIDDLE AGED; SKIN NEOPLASMS;

EID: 84892399084     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12629     Document Type: Article

References (13)

1. Epstein E,. Quantifying actinic keratosis: assessing the evidence. Am J Clin Dermatol 2004; 5: 141-4.
2. Lebwohl M, Swanson N, Anderson LL, et al,. Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012; 366: 1010-9.
3. Fenske NA, Spencer J, Adam F,. Actinic keratoses: past, present and future. J Drugs Dermatol 2010; 9 (5 Suppl. ODAC Conf Pt 1): s45-9.
4. Neidecker MV, Davis-Ajami ML, Balkrishnan R, Feldman SR,. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics 2009; 27: 451-64.
5. Warino L, Tusa M, Camacho F, et al,. Frequency and cost of actinic keratosis treatment. Dermatol Surg 2006; 32: 1045-9.
6. Frost C, Williams G, Green A,. High incidence and regression rates of solar keratosis in a Queensland community. J Invest Dermatol 2000; 115: 273-7.
7. Marks R, Foley P, Goodman G, et al,. Spontaneous remission of solar keratosis: the case for conservative management. Br J Dermatol 1986; 115: 649-55.
8. Van Ness PH, Towle VR, Juthani-Mehta M,. Testing measurement reliability in older populations: methods for informed discrimination in instrument selection and application. J Aging Health 2008; 20: 183-97.
9. Weinstock MA, Bingham SF, Cole GW, et al,. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial. Arch Dermatol 2001; 137: 1055-8.
10. Atkins D, Bang RH, Sternberg MR, Chen SC,. Reliable methods to evaluate the burden of actinic keratoses. J Invest Dermatol 2006; 126: 591-4.
11. Chen SC, Hill ND, Veledar E,. Reliability of quantification measures of actinic keratosis. Br J Dermatol 2013. [epub ahead of print].
12. Terushkin V, Braga JC, Dusza SW, et al,. Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms. Dermatol Surg 2010; 36: 1514-20.
13. Venna SS, Lee D, Stadecker MJ, Rogers GS,. Clinical recognition of actinic keratoses in a high-risk population: how good are we? Arch Dermatol 2005; 141: 507-9.